Dual antiplatelet Tx similar to aspirin post-CABG in diabete
For post-coronary artery bypass grafting (CABG) patients with diabetes, cardiovascular and bleeding outcomes do not differ significantly with use of dual antiplatelet therapy (DAPT) versus aspirin, according to a study published in the Jan. 17 issue of the Journal of the American College of Cardiology.

Sean van Diepen, M.D., from the University of Alberta in Edmonton, Canada, and colleagues compared patients receiving DAPT (aspirin plus thienopyridine) and aspirin monotherapy at 30 days postoperatively in a post-hoc nonrandomized analysis from the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of multivessel disease (FREEDOM) trial. The primary outcome was the risk-adjusted five-year FREEDOM composite of all-cause mortality, nonfatal myocardial infarction, or stroke.

http://medicalxpress.com/news/2017-01-dual-antiplatelet-tx-similar-aspirin.html
Like
Comment
Share